High blood pressure, also known as hypertension, is a serious public health threat globally. If uncontrolled it substantially increases the risk of disability and death from stroke, heart attacks and other cardiovascular conditions.
It’s also a huge problem in South Africa – an estimated 35% of people in the country older than 15 have high blood pressure. This is expected to increase as the country’s population rapidly ages over the coming decades.
It is therefore not surprising that the South African government has made blood pressure control a health policy priority.
But improving blood pressure control first requires figuring out what an ideal blood pressure should be. Blood pressure has two components: systolic - the amount of pressure in your arteries during the contraction of your heart muscle – and diastolic blood pressure – blood pressure when your heart muscle is between beats.
scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors
February 17, 2021 08:00 ET | Source: scPharmaceuticals, Inc. scPharmaceuticals, Inc. Burlington, Massachusetts, UNITED STATES
BURLINGTON, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the appointment of William T. Abraham, M.D., to the company’s Board of Directors. Dr. Abraham currently serves as Professor of Internal Medicine (Cardiology), Physiology and Cell Biology and College of Medicine Distinguished Professor at The Ohio State University as well as Chief Medical Officer at V-Wave Ltd., a privately held developer of percutaneous implantable therapeutic devices for
Employing cardiovascular disease prevention strategies in mid-life may delay or stop the brain alterations that can lead to dementia in later life, a new study suggests.The study, published in the Journal of the American College of Cardiology, .
Company news: Dr. Thomas J. Welch II joins St. Joseph’s Health Cardiovascular Institute
Updated Feb 16, 2021;
St. Joseph’s Health announced
Dr. Thomas J. Welch II has been hired by the St. Joseph’s Health Cardiovascular Institute in East Syracuse.
Dr. Welch earned his doctor of medicine degree from the
University of Virginia in Charlottesville and a bachelor’s degree in chemical engineering from the
University of Michigan in Ann Arbor. He completed a residency at the University of Virginia. He previosly was a fellow at the
University of Rochester focusing on complex coronary intervention and structural heart interventions.
Dr. Welch is board certified in cardiovascular disease and internal medicine. He specializes in interventional cardiology and is an active member of the American College of Cardiology.